Local News AGC Biologics Collaborates with Molecular Partners AG to Develop Anti-COVID-19 DARPin® Program AGC Biologics via PR Newswire | July 14, 2020 Global Biopharmaceutical Contract Development and Manufacturing Organization (CDMO) AGC Biologics is partnering with clinical-stage biotech company Molecular Partners…emcguinnJuly 14, 2020 Read More
Local News NIAID Creates Clinical Trials Network to Focus on COVID-19 Vaccines, Monoclonal Antibodies BioSpace | July 14, 2020 The National Institute of Allergy & Infectious Diseases (NIAID) has founded a new clinical trials network focused on enrolling…emcguinnJuly 14, 2020 Read More
Local News The Coronavirus Vaccine Timeline: The End in Sight? The Daily, UW | July 10, 2020 As the global confirmed COVID-19 cases count passes 10 million and cases in Washington state…emcguinnJuly 10, 2020 Read More
Local News After 20 Years, Wakefield Retires from HIV Vaccine Trials Network Fred Hutch | July 9, 2020 Fond words and accolades are rolling in for Steven Wakefield, who retired last week from…emcguinnJuly 9, 2020 Read More
Local News How to Precisely Edit Mitochondrial DNA Howard Hughes Medical Institute | July 9, 2020 Scientists can now precisely edit the genes inside mitochondria, the tiny energy factories inside of…emcguinnJuly 9, 2020 Read More
Local News Old Age Changes the Way Blood Accesses the Brain Allen Institute | July 8, 2020 In 1885, a German scientist named Paul Ehrlich made an odd discovery: If he injected…emcguinnJuly 8, 2020 Read More
Local News Seattle Researchers Team Up to Build Hi-Res Brain Map of Alzheimer’s Disease Allen Institute for Brain Science | July 7, 2020 If scientists understood how Alzheimer’s disease starts, they might have a better handle on how…eabramovichJuly 7, 2020 Read More
Local News Putting Genomics into Practice to Combat Common Diseases UW Medicine | July 6, 2020 Genomics carries great expectations: the power to help health-care providers assess and assist their patients…eabramovichJuly 6, 2020 Read More
Local News Seattle Genetics Announces Positive Topline Results from Phase 2 Clinical Trial of Tisotumab Vedotin in Recurrent or Metastatic Cervical Cancer Seattle Genetics | July 3, 2020 Seattle Genetics, Inc. (Nasdaq:SGEN) today announced positive topline results from the phase 2 single-arm clinical trial…eabramovichJuly 3, 2020 Read More
Local News Is Hydroxychloroquine Safe for Autoimmune Diseases? Benaroya Research Institute at Virginia Mason | July 3, 2020 COVID-19 has put a therapy called hydroxychloroquine in the spotlight — and, at the same…emcguinnJuly 3, 2020 Read More